x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Aug 17, 2016 2:23 EST

Sword Diagnostics: Accelerating Drug Development through dramatically enhanced sensitivity and reproducibility, without the need for special instrumentation, or complex processes

iCrowdNewswire - Aug 17, 2016

Sword 20red 20orange 20trans 20 5bsmall 5d

Sword Diagnostics

Accelerating Drug Development through dramatically enhanced sensitivity and reproducibility, without the need for special instrumentation, or complex processes.

Septem 20gust 20simple

Company Summary

 

Sword gives pharmaceutical companies the very thing they value most, a faster time to market. Sword enhances their 50 year old testing technology with higher sensitivity and precision, allowing scientists to make better decisions faster, accelerating drug development. Sword’s customers include Bristol-Myers Squibb, Eli Lilly, and Novartis, and the company is currently working with seven of the top 20 pharmaceutical companies in the world.

 
  • StageFull Product Ready
  • IndustryBiotechnology
  • LocationChicago, IL, US
  • CurrencyUSD
  • FoundedApril 2005
  • Employees13
  • Websitesworddx.com

 

Team

Contact Information:

Dave Dingott

View Related News >
support